The Grant endowed with CHF 20’000 was given to Dr. med. Matea Pavic for her project entitled “MR-guided Adaptive Stereotactic body radiotherapy (SBRT) for pain control in metastatic PAncreatic Cancer (mPDAC) - a randomized phase IIb/III trial”.

The aim of the SAKK/Celgene Life Grant is to support planned or ongoing research projects in pancreatic cancer care to reduce the burden of pancreatic cancer and improve the quality of life for patients and/or their relatives.

Prof. Dr. med. Roger von Moos (Jury President and SAKK President), Dr. med. Matea Pavic (University Hospital Zurich), Dr. Erich Weber (Celgene GmbH)